The role and potential of imaging in COPD

Medical Clinics of North America

Volumn 96, Issue 4, 2012, Pages 729-743

  Washko, George R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

COPD; CT scan; Imaging; MRI; OCT; PET

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FIBEROPTIC BRONCHOSCOPY; HUMAN; HYPOXIC LUNG VASOCONSTRICTION; INFLAMMATION; LUNG BIOPSY; LUNG EMBOLISM; LUNG EMPHYSEMA; LUNG PARENCHYMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; REVIEW; SMOKING; SPIROMETRY; THORAX RADIOGRAPHY;

AIRWAY REMODELING; HUMANS; MAGNETIC RESONANCE IMAGING; PHENOTYPE; POSITRON-EMISSION TOMOGRAPHY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TOMOGRAPHY, OPTICAL COHERENCE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84863840642     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2012.05.003     Document Type: Review

References (94)

1. Rabe K.F., Hurd S., Anzueto A., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: gold executive summary. Am J Respir Crit Care Med 2007, 176:532-555.
2. Barr R.G., Bluemke D.A., Ahmed F.S., et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010, 362:217-227.
3. Bon J., Fuhrman C.R., Weissfeld J.L., et al. Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. Am J Respir Crit Care Med 2011, 183:885-890.
4. Snider G.L. Emphysema: the first two centuries-and beyond. A historical overview, with suggestions for future research: part 1. Am Rev Respir Dis 1992, 146:1334-1344.
5. Webb W.R. Thin-section CT of the secondary pulmonary lobule: anatomy and the image-the 2004 Fleischer lecture. Radiology 2006, 239:322-338.
6. Sutinen S., Christoforidis A.J., Klugh G.A., et al. Roentgenologic criteria for the recognition of nonsymptomatic pulmonary emphysema. Correlation between roentgenologic findings and pulmonary pathology. Am Rev Respir Dis 1965, 91:69-76.
7. Nicklaus T.M., Stowell D.W., Christiansen W.R., et al. The accuracy of the roentgenologic diagnosis of chronic pulmonary emphysema. Am Rev Respir Dis 1966, 93:889-899.
8. Foster W.L., Pratt P.C., Roggli V.L., et al. Centrilobular emphysema: CT-pathologic correlation. Radiology 1986, 159:27-32.
9. Bergin C., Muller N., Nichols D.M., et al. The diagnosis of emphysema. A computed tomographic-pathologic correlation. Am Rev Respir Dis 1986, 133:541-546.
10. Hruban R.H., Meziane M.A., Zerhouni E.A., et al. High resolution computed tomography of inflation-fixed lungs. Pathologic-radiologic correlation of centrilobular emphysema. Am Rev Respir Dis 1987, 136:935-940.
11. Hayhurst M.D., MacNee W., Flenley D.C., et al. Diagnosis of pulmonary emphysema by computerised tomography. Lancet 1984, 2:320-322.
12. Muller N.L., Staples C.A., Miller R.R., et al " Density mask" An objective method to quantitate emphysema using computed tomography. Chest 1988, 94:782-787.
13. Kinsella M., Muller N.L., Abboud R.T., et al. Quantitation of emphysema by computed tomography using a " density mask" program and correlation with pulmonary function tests. Chest 1990, 97:315-321.
14. Stern E.J., Frank M.S. CT of the lung in patients with pulmonary emphysema: diagnosis, quantification, and correlation with pathologic and physiologic findings. AJR Am J Roentgenol 1994, 162:791-798.
15. Heremans A., Verschakelen J.A., Van fraeyenhoven L., et al. Measurement of lung density by means of quantitative CT scanning. A study of correlations with pulmonary function tests. Chest 1992, 102:805-811.
16. Gould G.A., Redpath A.T., Ryan M., et al. Lung CT density correlates with measurements of airflow limitation and the diffusing capacity. Eur Respir J 1991, 4:141-146.
17. Gevenois P.A., de Maertelaer V., De Vuyst P., et al. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995, 152:653-657.
18. Gevenois P.A., De Vuyst P., de Maertelaer V., et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1996, 154:187-192.
19. Hersh C.P., Washko G.R., Jacobson F.L., et al. Interobserver variability in the determination of upper lobe-predominant emphysema. Chest 2007, 131:424-431.
20. Washko G.R., Criner G.J., Mohsenifar Z., et al. Computed tomographic-based quantification of emphysema and correlation to pulmonary function and mechanics. COPD 2008, 5:177-186.
21. Fishman A., Martinez F., Naunheim K., et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003, 348:2059-2073.
22. Uppaluri R., Mitsa T., Sonka M., et al. Quantification of pulmonary emphysema from lung computed tomography images. Am J Respir Crit Care Med 1997, 156:248-254.
23. Uppaluri R., Hoffman E.A., Sonka M., et al. Computer recognition of regional lung disease patterns. Am J Respir Crit Care Med 1999, 160:648-654.
24. Chabat F., Yang G.Z., Hansell D.M. Obstructive lung diseases: texture classification for differentiation at ct. Radiology 2003, 228:871-877.
25. Sluimer I.C., van Waes P.F., Viergever M.A., et al. Computer-aided diagnosis in high resolution CT of the lungs. Med Phys 2003, 30:3081-3090.
26. Sorensen L., Shaker S.B., de Bruijne M. Quantitative analysis of pulmonary emphysema using local binary patterns. IEEE Trans Med Imaging 2010, 29:559-569.
27. Xu Y., Sonka M., McLennan G., et al. MDCT-based 3-d texture classification of emphysema and early smoking related lung pathologies. IEEE Trans Med Imaging 2006, 25:464-475.
28. Lederer D.J., Enright P.L., Kawut S.M., et al. Cigarette smoking is associated with subclinical parenchymal lung disease: the multi-ethnic study of atherosclerosis (mesa)-lung study. Am J Respir Crit Care Med 2009, 180:407-414.
29. Washko G.R., Hunninghake G.M., Fernandez I.E., et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011, 364:897-906.
30. Tsushima K., Sone S., Yoshikawa S., et al. The radiological patterns of interstitial change at an early phase: over a 4-year follow-up. Respir Med 2010, 104:1712-1721.
31. Hogg J.C., Macklem P.T., Thurlbeck W.M. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968, 278:1355-1360.
32. Nakano Y., Muro S., Sakai H., et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000, 162:1102-1108.
33. Nakano Y., Wong J.C., de Jong P.A., et al. The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med 2005, 171:142-146.
34. Hasegawa M., Nasuhara Y., Onodera Y., et al. Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 173:1309-1315.
35. Washko G.R., Dransfield M.T., Estepar R.S., et al. Airway wall attenuation: a biomarker of airway disease in subjects with COPD. J Appl Physiol 2009, 107:185-191.
36. Hogg J.C., McDonough J.E., Sanchez P.G., et al. Micro-computed tomography measurements of peripheral lung pathology in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009, 6:546-549.
37. Diaz A.A., Valim C., Yamashiro T., et al. Airway count and emphysema assessed by chest CT imaging predicts clinical outcome in smokers. Chest 2010, 138:880-887.
38. Coxson H.O., Rogers R.M., Whittall K.P., et al. A quantification of the lung surface area in emphysema using computed tomography. Am J Respir Crit Care Med 1999, 159:851-856.
39. Chatila W.M., Thomashow B.M., Minai O.A., et al. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008, 5:549-555.
40. Falk J.A., Kadiev S., Criner G.J., et al. Cardiac disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008, 5:543-548.
41. Chaouat A., Naeije R., Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J 2008, 32:1371-1385.
42. Hasleton P.S., Heath D., Brewer D.B. Hypertensive pulmonary vascular disease in states of chronic hypoxia. J Pathol Bacteriol 1968, 95:431-440.
43. Barbera J.A., Riverola A., Roca J., et al. Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994, 149:423-429.
44. Peinado V.I., Barbera J.A., Ramirez J., et al. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am J Physiol 1998, 274:L908-L913.
45. Hale K.A., Niewoehner D.E., Cosio M.G. Morphologic changes in the muscular pulmonary arteries: relationship to cigarette smoking, airway disease, and emphysema. Am Rev Respir Dis 1980, 122:273-278.
46. Matsuoka S., Washko G.R., Dransfield M.T., et al. Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitation. Acad Radiol 2010, 17:93-99.
47. Matsuoka S., Washko G.R., Yamashiro T., et al. Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema. Am J Respir Crit Care Med 2010, 181:218-225.
48. Matsuoka S., Yamashiro T., Diaz A., et al. The relationship between small pulmonary vascular alteration and aortic atherosclerosis in chronic obstructive pulmonary disease: quantitative CT analysis. Acad Radiol 2011, 18:40-46.
49. Alford S.K., van Beek E.J., McLennan G., et al. Heterogeneity of pulmonary perfusion as a mechanistic image-based phenotype in emphysema susceptible smokers. Proc Natl Acad Sci U S A 2010, 107:7485-7490.
50. Han M.K., Kazerooni E.A., Lynch D.A., et al. Chronic obstructive pulmonary disease exacerbations in the COPD gene study: associated radiologic phenotypes. Radiology 2011, 261(1):274-282.
51. Sciurba F.C., Ernst A., Herth F.J., et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010, 363:1233-1244.
52. Smith-Bindman R. Is computed tomography safe?. N Engl J Med 2010, 363:1-4.
53. Smith-Bindman R., Lipson J., Marcus R., et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 2009, 169:2078-2086.
54. Petty T.L. Are COPD and lung cancer two manifestations of the same disease?. Chest 2005, 128:1895-1897.
55. Wilson D.O., Weissfeld J.L., Balkan A., et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008, 178:738-744.
56. de Torres J.P., Bastarrika G., Wisnivesky J.P., et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 2007, 132:1932-1938.
57. International Early Lung Cancer Action Program Investigators, Henschke C.I., Yankelevitz D.F., et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006, 355:1763-1771.
58. Infante M., Cavuto S., Lutman F.R., et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the Dante trial. Am J Respir Crit Care Med 2009, 180:445-453.
59. Gohagan J.K., Marcus P.M., Fagerstrom R.M., et al. Final results of the lung screening study, a randomized feasibility study of spiral CT versus chest x-ray screening for lung cancer. Lung Cancer 2005, 47:9-15.
60. Marcus P.M., Bergstralh E.J., Fagerstrom R.M., et al. Lung cancer mortality in the mayo lung project: impact of extended follow-up. J Natl Cancer Inst 2000, 92:1308-1316.
61. National Lung Screening Trial Research Team, Aberle D.R., Adams A.M., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365:395-409.
62. Henschke C.I., McCauley D.I., Yankelevitz D.F., et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet 1999, 354:99-105.
63. Sone S., Takashima S., Li F., et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998, 351:1242-1245.
64. Wilson D.O., Weissfeld J.L., Fuhrman C.R., et al. The Pittsburgh lung screening study (PLUSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med 2008, 178:956-961.
65. Happer W. Spin exchange, past, present and future. Ann Phys Fr 1985, 10:645-657.
66. Yablonskiy D.A., Sukstanskii A.L., Woods J.C., et al. Quantification of lung microstructure with hyperpolarized 3he diffusion MRI. J Appl Physiol 2009, 107:1258-1265.
67. Patz S.M.I., Hrovat M.I., Dabaghyan M., et al. Diffusion of hyperpolarized 129xe in the lung: a simplified model of 129xe septal uptake and experimental results. New J Phys 2011, 13:2-18.
68. Driehuys B., Cofer G.P., Pollaro J., et al. Imaging alveolar-capillary gas transfer using hyperpolarized 129xe MRI. Proc Natl Acad Sci U S A 2006, 103:18278-18283.
69. Patz S., Hersman F.W., Muradian I., et al. Hyperpolarized (129)xe MRI: a viable functional lung imaging modality?. Eur J Radiol 2007, 64:335-344.
70. Patz S., Muradian I., Hrovat M.I., et al. Human pulmonary imaging and spectroscopy with hyperpolarized 129xe at 0.2t. Acad Radiol 2008, 15:713-727.
71. Ruppert K., Mata J.F., Brookeman J.R., et al. Exploring lung function with hyperpolarized (129)xe nuclear magnetic resonance. Magn Reson Med 2004, 51:676-687.
72. Mansson S., Wolber J., Driehuys B., et al. Characterization of diffusing capacity and perfusion of the rat lung in a lipopolysaccharide disease model using hyperpolarized 129xe. Magn Reson Med 2003, 50:1170-1179.
73. Deninger A.J., Eberle B., Bermuth J., et al. Assessment of a single-acquisition imaging sequence for oxygen-sensitive (3)He-MRI. Magn Reson Med 2002, 47:105-114.
74. Deninger A.J., Mansson S., Petersson J.S., et al. Quantitative measurement of regional lung ventilation using 3He MRI. Magn Reson Med 2002, 48:223-232.
75. Mansson S., Deninger A.J., Magnusson P., et al. 3He MRI-based assessment of posture-dependent regional ventilation gradients in rats. J Appl Physiol 2005, 98:2259-2267.
76. de Lange E.E., Mugler J.P., Brookeman J.R., et al. Lung air spaces: MR imaging evaluation with hyperpolarized 3He gas. Radiology 1999, 210:851-857.
77. Kauczor H.U., Hofmann D., Kreitner K.F., et al. Normal and abnormal pulmonary ventilation: visualization at hyperpolarized He-3 MR imaging. Radiology 1996, 201:564-568.
78. MacFall J.R., Charles H.C., Black R.D., et al. Human lung air spaces: potential for MR imaging with hyperpolarized He-3. Radiology 1996, 200:553-558.
79. Woodhouse N., Wild J.M., Paley M.N., et al. Combined helium-3/proton magnetic resonance imaging measurement of ventilated lung volumes in smokers compared to never-smokers. J Magn Reson Imaging 2005, 21:365-369.
80. McLure L.E., Peacock A.J. Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension. Eur Respir J 2009, 33:1454-1466.
81. Bottini P.B., Carr A.A., Prisant L.M., et al. Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am J Hypertens 1995, 8:221-228.
82. Grothues F., Smith G.C., Moon J.C., et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002, 90:29-34.
83. Benza R., Biederman R., Murali S., et al. Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension. J Am Coll Cardiol 2008, 52:1683-1692.
84. Bogren H.G., Klipstein R.H., Mohiaddin R.H., et al. Pulmonary artery distensibility and blood flow patterns: a magnetic resonance study of normal subjects and of patients with pulmonary arterial hypertension. Am Heart J 1989, 118:990-999.
85. Gan C.T., Lankhaar J.W., Westerhof N., et al. Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest 2007, 132:1906-1912.
86. Jardim C., Rochitte C.E., Humbert M., et al. Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study. Eur Respir J 2007, 29:476-481.
87. Amundsen T., Kvaerness J., Jones R.A., et al. Pulmonary embolism: detection with MR perfusion imaging of lung-a feasibility study. Radiology 1997, 203:181-185.
88. Hatabu H., Gaa J., Kim D., et al. Pulmonary perfusion: qualitative assessment with dynamic contrast-enhanced MRI using ultra-short TE and inversion recovery turbo flash. Magn Reson Med 1996, 36:503-508.
89. Hatabu H., Gaa J., Kim D., et al. Pulmonary perfusion and angiography: evaluation with breath-hold enhanced three-dimensional fast imaging steady-state precession MR imaging with short TR and TE. AJR Am J Roentgenol 1996, 167:653-655.
90. Berthezene Y., Croisille P., Wiart M., et al. Prospective comparison of MR lung perfusion and lung scintigraphy. J Magn Reson Imaging 1999, 9:61-68.
91. Kirby M., Mathew L., Wheatley A., et al. Chronic obstructive pulmonary disease: longitudinal hyperpolarized (3)He MR imaging. Radiology 2010, 256:280-289.
92. Vidal Melo M.F., Winkler T., Harris R.S., et al. Spatial heterogeneity of lung perfusion assessed with (13)N PET as a vascular biomarker in chronic obstructive pulmonary disease. J Nucl Med 2010, 51:57-65.
93. Coxson H.O., Quiney B., Sin D.D., et al. Airway wall thickness assessed using computed tomography and optical coherence tomography. Am J Respir Crit Care Med 2008, 177:1201-1206.
94. Coxson H.O., Mayo J., Lam S., et al. New and current clinical imaging techniques to study chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009, 180:588-597.